
- University of the Witwatersrand South Africa
- UNIVERSIDADE DE LISBOA Portugal
- University of Alberta Canada
- University of Lisbon Portugal
- UNIVERSIDADE DE LISBOA Portugal
- Stanford University United States
- University of Sydney Australia
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Netherlands
- Universidade de Lisboa Portugal
- Universidade de Lisboa Portugal
- University of Lisbon Portugal
- Academic Medical Center Netherlands
- Hospital de Santa Maria Portugal
- UNIVERSIDADE DE LISBOA Portugal
- Emma Kinderziekenhuis Netherlands
- Universtity of Sydney Australia
- Universitiy of Pennsylvania United States
- UNIVERSIDADE DE LISBOA Portugal
- Universidade de Lisboa Portugal
- UNIVERSIDADE DE LISBOA Portugal
- University of Pennsylvania United States
- Academisch Medisch Centrum bij de Universiteit van Amsterdam Netherlands
- Stanford University School of Medicine United States
- University Malaya Medical Centre Malaysia
- University of Zurich Switzerland
- University Hospital and Clinics United States
- Zurich University of the Arts Switzerland
- UNIVERSIDADE DE LISBOA Portugal
- Amsterdam UMC - Vrije Universiteit Amsterdam Netherlands
- Universidade de Lisboa Portugal
Background: We wished to compare the nuisance parameters of pediatric vs. adult randomized-trials (RCTs) and determine if the latter can be used in sample size computations of the former.Methods: In this meta-epidemiologic empirical evaluation we examined meta-analyses from the Cochrane Database of Systematic-Reviews, with at least one pediatric-RCT and at least one adult-RCT. Within each meta-analysis of binary efficacy-outcomes, we calculated the pooled-control-group event-rate (CER) across separately all pediatric and adult-trials, using random-effect models and subsequently calculated the control-group event-rate risk-ratio (CER-RR) of the pooled-pediatric-CERs vs. adult-CERs. Within each meta-analysis with continuous outcomes we calculated the pooled-control-group effect standard deviation (CE-SD) across separately all pediatric and adult-trials and subsequently calculated the CE-SD-ratio of the pooled-pediatric-CE-SDs vs. adult-CE-SDs. We then calculated across all meta-analyses the pooled-CER-RRs and pooled-CE-SD-ratios (primary endpoints) and the pooled-magnitude of effect-sizes of CER-RRs and CE-SD-ratios using REMs. A ratio < 1 indicates that pediatric trials have smaller nuisance parameters than adult trials.Results: We analyzed 208 meta-analyses (135 for binary-outcomes, 73 for continuous-outcomes). For binary outcomes, pediatric-RCTs had on average 10% smaller CERs than adult-RCTs (summary-CE-RR: 0.90; 95% CI: 0.83, 0.98). For mortality outcomes the summary-CE-RR was 0.48 (95% CIs: 0.31, 0.74). For continuous outcomes, pediatric-RCTs had on average 26% smaller CE-SDs than adult-RCTs (summary-CE-SD-ratio: 0.74).Conclusions: Clinically relevant differences in nuisance parameters between pediatric and adult trials were detected. These differences have implications for design of future studies. Extrapolation of nuisance parameters for sample-sizes calculations from adult-trials to pediatric-trials should be cautiously done.